212 related articles for article (PubMed ID: 23965767)
1. Retreatment rates for uncomplicated gonorrhea infection: comparing ceftriaxone and azithromycin versus ceftriaxone and doxycycline.
Schumacher CM; Ghanem KG
Sex Transm Dis; 2013 Jul; 40(7):539-45. PubMed ID: 23965767
[TBL] [Abstract][Full Text] [Related]
2. Update to CDC's Sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Aug; 61(31):590-4. PubMed ID: 22874837
[TBL] [Abstract][Full Text] [Related]
3. Gonorrhea Treatment Failures With Oral and Injectable Expanded Spectrum Cephalosporin Monotherapy vs Dual Therapy at 4 Canadian Sexually Transmitted Infection Clinics, 2010-2013.
Singh AE; Gratrix J; Martin I; Friedman DS; Hoang L; Lester R; Metz G; Ogilvie G; Read R; Wong T
Sex Transm Dis; 2015 Jun; 42(6):331-6. PubMed ID: 25970311
[TBL] [Abstract][Full Text] [Related]
4. Variation in adherence to the treatment guidelines for Neisseria gonorrhoeae by clinical practice setting, California, 2009 to 2011.
Lechtenberg RJ; Samuel MC; Bernstein KT; Lahiff M; Olson N; Bauer HM
Sex Transm Dis; 2014 May; 41(5):338-44. PubMed ID: 24722391
[TBL] [Abstract][Full Text] [Related]
5. Update on Emerging Infections: news from the Centers for Disease Control and Prevention. Update to the CDC’s Sexually Transmitted Diseases Treatment Guidelines, 2010: Oral cephalosporins no longer a recommended treatment for gonococcal infections .
Maldonado NG; Takhar SS
Ann Emerg Med; 2013 Jan; 61(1):91-5. PubMed ID: 23260686
[No Abstract] [Full Text] [Related]
6. Neisseria gonorrhoeae with reduced susceptibility to azithromycin--San Diego County, California, 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 May; 60(18):579-81. PubMed ID: 21566558
[TBL] [Abstract][Full Text] [Related]
7. Committee Opinion No. 645: Dual Therapy for Gonococcal Infections.
Obstet Gynecol; 2016 May; 127(5):e95-9. PubMed ID: 27548425
[TBL] [Abstract][Full Text] [Related]
8. Adherence to Centers for Disease Control and Prevention Gonococcal Treatment Guidelines Among Chicago Health Care Providers, 2011-2012.
Tabidze IL; Nicholson TF; Mikati T; Benbow N; Mehta SD
Sex Transm Dis; 2015 Aug; 42(8):422-8. PubMed ID: 26165433
[TBL] [Abstract][Full Text] [Related]
9. Will use of combination cephalosporin/azithromycin therapy forestall resistance to cephalosporins in Neisseria gonorrhoeae?
Rice LB
Sex Transm Infect; 2015 Jun; 91(4):238-40. PubMed ID: 25926405
[No Abstract] [Full Text] [Related]
10. An outbreak of high-level azithromycin resistant Neisseria gonorrhoeae in England.
Chisholm SA; Wilson J; Alexander S; Tripodo F; Al-Shahib A; Schaefer U; Lythgow K; Fifer H
Sex Transm Infect; 2016 Aug; 92(5):365-7. PubMed ID: 26601852
[TBL] [Abstract][Full Text] [Related]
11. Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010.
Ison CA; Hussey J; Sankar KN; Evans J; Alexander S
Euro Surveill; 2011 Apr; 16(14):. PubMed ID: 21492528
[TBL] [Abstract][Full Text] [Related]
12. Treatment of gonococcal infection: when one drug is not enough.
Kransdorf LN; Kling JM; Mayer AP
J Womens Health (Larchmt); 2014 Jul; 23(7):627-8. PubMed ID: 24918549
[No Abstract] [Full Text] [Related]
13. Gonorrhoea treatment position statement.
Fifer H; Hughes G; Radcliffe K
Sex Transm Infect; 2015 Aug; 91(5):307. PubMed ID: 26195472
[No Abstract] [Full Text] [Related]
14. Diagnosis and management of gonococcal infections.
Mayor MT; Roett MA; Uduhiri KA
Am Fam Physician; 2012 Nov; 86(10):931-8. PubMed ID: 23157146
[TBL] [Abstract][Full Text] [Related]
15. Partner Therapy in Sexually Transmitted Infections: A Teachable Moment.
Keshvani N; Nijhawan A; Gupta A
JAMA Intern Med; 2018 Aug; 178(8):1108-1109. PubMed ID: 29889926
[No Abstract] [Full Text] [Related]
16. First line dual therapy for gonorrhoea to limit the spread of antimicrobial resistance.
Mohammed H; Sile B; Furegato M; Woodhall S; Fifer H; Hughes G
BMJ; 2017 Feb; 356():j565. PubMed ID: 28153820
[No Abstract] [Full Text] [Related]
17. Gonorrhea treatment practices in the STD Surveillance Network, 2010-2012.
Kerani RP; Stenger MR; Weinstock H; Bernstein KT; Reed M; Schumacher C; Samuel MC; Eaglin M; Golden M
Sex Transm Dis; 2015 Jan; 42(1):6-12. PubMed ID: 25504294
[TBL] [Abstract][Full Text] [Related]
18. [Non-viral sexually transmitted infections - Epidemiology, clinical manifestations, diagnostics and therapy : Part 1: Gonococci].
Nenoff P; Manos A; Ehrhard I; Krüger C; Paasch U; Helmbold P; Handrick W
Hautarzt; 2017 Jan; 68(1):43-49. PubMed ID: 27981386
[TBL] [Abstract][Full Text] [Related]
19. Cost-Effectiveness of Dual Antimicrobial Therapy for Gonococcal Infections Among Men Who Have Sex With Men in the Netherlands.
Xiridou M; Lugnér A; de Vries HJ; van Bergen JE; Götz HM; van Benthem BH; Wallinga J; van der Sande MA
Sex Transm Dis; 2016 Sep; 43(9):542-8. PubMed ID: 27513379
[TBL] [Abstract][Full Text] [Related]
20. First cases of Neisseria gonorrhoeae resistant to ceftriaxone in Catalonia, Spain, May 2011.
Carnicer-Pont D; Smithson A; Fina-Homar E; Bastida MT;
Enferm Infecc Microbiol Clin; 2012 Apr; 30(4):218-9. PubMed ID: 22244992
[No Abstract] [Full Text] [Related]
[Next] [New Search]